Jiangxi Zhenshiming Pharmaceutical Co., Ltd. announced that it has received A+ round of funding on April 16, 2024. The transaction included participation from new and returning investors Zhejiang CONBA Pharmaceutical Co.,Ltd., Fuzhou Digital Economy Investment Group Co., Ltd. and Gold Stone Investment Co., Ltd.